The Effect of Virtual Reality Glasses on Vital Signs and State Anxiety in Patients Undergoing Coronary Angiography

NCT07032935 | Completed DMC

• 1 other identifier: KutahyaHSU20240106
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

Virtual reality (VR) glasses are an effective non-pharmacological method for reducing anxiety, supported by a high level of evidence and associated with no known side effects. Techniques involving relaxation and distraction, such as VR, function by suppressing the sympathetic branch of the autonomic nervous system and activating the parasympathetic branch, thereby eliciting a relaxation response. VR glasses divert the patient's attention away from pain and anxiety. By reducing the sense of unfamiliarity in clinical environments, VR helps patients adapt more easily, leading to enhanced relaxation. This state of relaxation not only alleviates anxiety but also induces favorable physiological responses. These include reductions in blood pressure (BP), heart rate (HR), and respiratory rate (RR), along with an increase in peripheral oxygen saturation (SpO₂). Additionally, the psychological benefits of VR contribute to the reduction of anxiety, stress, fear, and worry. VR is considered a cost-effective, safe, and non-pharmacological intervention. Several studies support its efficacy. For example, in a study comparing the effects of video games played through VR headsets and iPads on preoperative anxiety in adult patients undergoing sternotomy, anxiety was measured using the Depression Anxiety Stress Scale (DASS), and lower anxiety levels were observed in the VR group. Another study demonstrated that watching nature scenes through VR glasses for five minutes prior to maxillofacial surgery significantly reduced anxiety. Furthermore, research comparing progressive muscle relaxation exercises and VR during arthroscopic knee surgery-measured using the State Anxiety Inventory-indicated that both non-pharmacological interventions were effective in reducing anxiety. However, despite this growing body of evidence, no study to date has examined the effects of VR applications on anxiety in patients undergoing coronary angiography or pacemaker implantation. This study aims to fill that gap by investigating the comparative effectiveness of virtual reality applications in reducing anxiety in patients undergoing coronary angiography.

Conditions

Coronary Angiography (CAG)

Keywords

coronary angiography; virtual reality glasses; anxiety; vital signs

Outcome Measures

Primary Outcomes (1)

• Change in State Anxiety Score

  Before and after the intervention (pre- and post-intervention) It will be measured using the State Anxiety Inventory (STAI-I). The score varies between 20 and 80.

  Before the intervention (15 minutes before the procedure), and within the first 15 minutes after the intervention is completed

Secondary Outcomes (3)

• Change in Vital Signs (Heart Rate)

  Before the intervention (15 minutes before the procedure), and within the first 15 minutes after the intervention is completed

• Change in Vital Signs (Blood Pressure)

  Before the intervention (15 minutes before the procedure), and within the first 15 minutes after the intervention is completed

• Change in Vital Signs (Respiratory Rate)

  Before the intervention (15 minutes before the procedure), and within the first 15 minutes after the intervention is completed

Study Arms (2)

Control Group

NO INTERVENTION

No intervention will be made to the patient during the Coronary Angiography application.

virtual reality glasses Group

EXPERIMENTAL

Behavioral: Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

Interventions

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION BEHAVIORAL

Virtual Reality Glasses will be used DURING CORONARY ANGIOGRAPHY APPLICATION

virtual reality glasses Group

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Are over 18 years of age,
• Do not have any psychiatric illness,
• Do not have any vision, hearing or perception problems,
• Are at least a primary school graduate,
• Do not have any disorder/disease affecting decision-making ability (dementia, psychological disorder, etc.)
• Volunteer to participate in the study,
• Are open to communication and cooperation.

You may not qualify if:

• Patients who receive sedation, patients who cannot communicate, patients with visual or hearing impairments, and individuals who do not agree to participate in the research will be included.

Sponsors & Collaborators

• Kutahya Health Sciences University: lead

Study Sites (1)

Kutahya Health Sciences University

Merkez, Kütahya, 43200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: virtual reality glasses

Study Record Dates

• First Submitted: June 11, 2025
• First Posted: June 24, 2025
• Study Start: July 15, 2025
• Primary Completion: August 15, 2025
• Study Completion: August 15, 2025
• Last Updated: September 3, 2025

Record last verified: 2025-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)